American Journal of Ophthalmology
Volume 137, Issue 2 , Pages 287-293, February 2004

Perfluorocarbon perfused vitrectomy: animal studies

This study was presented in part at the Retina Congress at the Joint Meeting of the 35th Retina Society and 20th Vitreous Society, San Francisco, California, September 29, 2002; and the XXIV Pan-American Congress of Ophthalmology, American Journal of Ophthalmology Lecture, Puerto Rico, March 2003.

  • Hugo Quiroz-Mercado, MD

      Affiliations

    • Retina Service, Hospital Luis Sánchez Bulnes, Asociación para Evitar la Ceguera en México, México City, Mexico
    • Corresponding Author InformationInquiries to Hugo Quiroz-Mercado, MD, Retina Service, Hospital Luis Sanchez Bulnes, Asociacion para Evitar la Ceguera en México, Vicente García Torres 46, México DF 04330, Mexico; fax: 5255-5659-5928
  • ,
  • Luis Suarez-Tatá, MD

      Affiliations

    • Retina Service, Hospital Luis Sánchez Bulnes, Asociación para Evitar la Ceguera en México, México City, Mexico
  • ,
  • Rudi Magdalenic, MD

      Affiliations

    • Retina Service, Hospital Luis Sánchez Bulnes, Asociación para Evitar la Ceguera en México, México City, Mexico
  • ,
  • Sergio Murillo-López, MD

      Affiliations

    • Retina Service, Hospital Luis Sánchez Bulnes, Asociación para Evitar la Ceguera en México, México City, Mexico
  • ,
  • Gerardo García-Aguirre, MD

      Affiliations

    • Retina Service, Hospital Luis Sánchez Bulnes, Asociación para Evitar la Ceguera en México, México City, Mexico
  • ,
  • Jose Guerrero-Naranjo, MD

      Affiliations

    • Retina Service, Hospital Luis Sánchez Bulnes, Asociación para Evitar la Ceguera en México, México City, Mexico
  • ,
  • Abelardo A. Rodríguez-Reyes, MD

      Affiliations

    • Retina Service, Hospital Luis Sánchez Bulnes, Asociación para Evitar la Ceguera en México, México City, Mexico

Accepted 10 August 2003.

Abstract 

Purpose

To investigate the feasibility and advantages of using perfluorocarbon liquid (PCL) perfusion to remove vitreous during suction-cutting vitrectomy in rabbit and pig eyes.

Design

Experimental study.

Methods

Balanced salt solution (BSS) was replaced by PCL perfusion during experimental vitrectomy. Oxygenated or nonoxygenated PCL was used in a recycling or a nonrecycling system. Recycling was achieved by two systems: a manual recycling system or a closed-loop system. The experiments in this study consisted of: an in vitro solubility observation, safety and feasibility of vitrectomy in rabbit eyes, effectiveness of vitrectomy with equal vitrectomy time in rabbit eyes, and retinal stability and pigment and blood dispersion in porcine eyes. Toxicity was assessed by a complete ophthalmic examination, endothelial cell count, electroretinography, and histopathology.

Results

Vitreous, blood, and pigments were immiscible in PCL. Manual recycling required less amounts of PCL than nonrecycling (15 vs 25 cc). Oxygenated and nonoxygenated PCL were not toxic. Perfluorocarbon liquid infusion removed more vitreous than balanced salt solution in a 3-minute vitrectomy time using the same settings on the vitrectomy machine. The PCL infusion in porcine eyes stabilized the retina and isolated vitreous cavity from pigment and blood and maintained a clear vitreous cavity.

Conclusions

These data indicate that perfusion of PCL can be used to remove vitreous with a suction-cutting probe in rabbit and pig eyes. Retinal stability and isolation of the vitreous cavity at the time of vitreous removal along with PCL immiscibility and its specific gravity suggest that PCL has a potential clinical use as an irrigating solution to remove vitreous.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Biosketches and/or additional material at www.ajo.com doi:10.1016/j.ajo.2003.08.03

PII: S0002-9394(03)00971-1

doi:10.1016/j.ajo.2003.08.033

American Journal of Ophthalmology
Volume 137, Issue 2 , Pages 287-293, February 2004